The FAERS database had 4,895 (0.060%) reports of interstitial nephritis among 8,281,917 cases in the non-FXa inhibitor group) and only 52 (0.039%) reports among 132,591 cases in the FXa inhibitor group (odds ratio 0.65; 95% CI 0.49–0.85). This evidence concerns the gene F10 and interstitial nephritis.